Insmed Inc (INSM)

[elmono]

still believe that if the company (INSM) heavily overestimated its own future sales (2006), this is not a good sign and might be indicative for years to come, as far as the current approved indication is concerned. I find it realy strange that the experts in the field where so dead wrong about this. But hey, what do we care, because everything will turn rosy next year or so